Skip to main content
Top
Published in: Drugs & Aging 2/2007

01-02-2007 | Original Research Article

Evolution of Medication Use in Jerusalem Elders

Results from the Jerusalem Longitudinal Study

Authors: Dr Michael A. Steinman, Yoram Maaravi, Louise C. Walter, Robert Hammerman-Rozenberg, Jochanan Stessman

Published in: Drugs & Aging | Issue 2/2007

Login to get access

Abstract

Background

While overall rates of medication use have been increasing over time, less is known about how medication use changes within individuals as they age.

Objective

The aim of this study was to evaluate changes in medication use and predictors of medication accrual among community-dwelling elders followed for a 7-year period, from age 70 ± 1 years to age 77 ± 1 years.

Methods

The study was a community-based, longitudinal, cohort study. The study group consisted of 280 patients from the Jerusalem Longitudinal Study, a population-based sample of Jerusalem residents born in 1920–1 who underwent extensive evaluation in 1990–1 and again in 1997–8. The main outcome measure of the study was the change in the total number of medications taken between baseline and follow-up. Medication use was assessed by home interviews.

Results

Half of the sample were men. Medication use more than doubled over the 7-year study period, from a mean of 2.0 to 5.3 medications per patient (p < 0.001), and 57 patients (20%) increased their total drug use by six or more medications. Vitamins, minerals and cardiovascular medications were the most commonly prescribed medications at follow-up, and accounted for approximately half of the total increase in medication use. On multivariable logistic regression analyses, decline in self-rated health was the strongest predictor of above-median increases in medication use (odds ratio [OR] 3.2; 95% CI 1.8, 6.2). The only nonclinical predictor of above-median increases in medication use was good social engagement at baseline (OR 1.8; 95% CI 1.1, 3.1).

Conclusion

Medication use in Jerusalem elders grew rapidly over the 1990s, more than doubling in volume over a 7-year period. While health status was the factor most strongly predictive of the degree of change, the magnitude of increase for elders as a whole suggests major changes in prescribing practices over this interval.
Literature
1.
go back to reference Gurwitz JH. Polypharmacy: a new paradigm for quality drug therapy in the elderly? Arch Intern Med 2004; 164: 1957–9PubMedCrossRef Gurwitz JH. Polypharmacy: a new paradigm for quality drug therapy in the elderly? Arch Intern Med 2004; 164: 1957–9PubMedCrossRef
2.
go back to reference Field TS, Gurwitz JH, Harrold LR, et al. Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc 2004; 52: 1349–54PubMedCrossRef Field TS, Gurwitz JH, Harrold LR, et al. Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc 2004; 52: 1349–54PubMedCrossRef
4.
go back to reference Vik SA, Maxwell CJ, Hogan DB. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother 2004; 38: 303–12PubMed Vik SA, Maxwell CJ, Hogan DB. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother 2004; 38: 303–12PubMed
5.
go back to reference Steinman MA, Sands LP, Covinsky KE. Self-restriction of medications due to cost in seniors without prescription coverage. J Gen Intern Med 2001; 16: 793–9PubMedCrossRef Steinman MA, Sands LP, Covinsky KE. Self-restriction of medications due to cost in seniors without prescription coverage. J Gen Intern Med 2001; 16: 793–9PubMedCrossRef
6.
go back to reference Linjakumpu T, Hartikainen S, Klaukka T, et al. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol 2002; 55: 809–17PubMedCrossRef Linjakumpu T, Hartikainen S, Klaukka T, et al. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol 2002; 55: 809–17PubMedCrossRef
7.
go back to reference Stewart RB, Moore MT, May FE, et al. A longitudinal evaluation of drug use in an ambulatory elderly population. J Clin Epidemiol 1991; 44: 1353–9PubMedCrossRef Stewart RB, Moore MT, May FE, et al. A longitudinal evaluation of drug use in an ambulatory elderly population. J Clin Epidemiol 1991; 44: 1353–9PubMedCrossRef
8.
go back to reference Jylha M. Ten-year change in the use of medical drugs among the elderly: a longitudinal study and cohort comparison. J Clin Epidemiol 1994; 47: 69–79PubMedCrossRef Jylha M. Ten-year change in the use of medical drugs among the elderly: a longitudinal study and cohort comparison. J Clin Epidemiol 1994; 47: 69–79PubMedCrossRef
9.
go back to reference Chrischilles EA, Foley DJ, Wallace RB, et al. Use of medications by persons 65 and over: data from the established populations for epidemiologic studies of the elderly. J Gerontol 1992; 47: M137–44PubMedCrossRef Chrischilles EA, Foley DJ, Wallace RB, et al. Use of medications by persons 65 and over: data from the established populations for epidemiologic studies of the elderly. J Gerontol 1992; 47: M137–44PubMedCrossRef
10.
go back to reference Lernfelt B, Samuelsson O, Skoog I, et al. Changes in drug treatment in the elderly between 1971 and 2000. Eur J Clin Pharmacol 2003; 59: 637–44PubMedCrossRef Lernfelt B, Samuelsson O, Skoog I, et al. Changes in drug treatment in the elderly between 1971 and 2000. Eur J Clin Pharmacol 2003; 59: 637–44PubMedCrossRef
11.
go back to reference Veehof L, Stewart R, Haaijer-Ruskamp F, et al. The development of polypharmacy. A longitudinal study. Fam Pract 2000; 17: 261–7PubMedCrossRef Veehof L, Stewart R, Haaijer-Ruskamp F, et al. The development of polypharmacy. A longitudinal study. Fam Pract 2000; 17: 261–7PubMedCrossRef
12.
go back to reference Stuart B, Coulson NE. Dynamic aspects of prescription drug use in an elderly population. Health Serv Res 1993; 28: 237–64PubMed Stuart B, Coulson NE. Dynamic aspects of prescription drug use in an elderly population. Health Serv Res 1993; 28: 237–64PubMed
13.
go back to reference Kouzis AC, Eaton WM. Absence of social networks, social support, and health services utilization. Psychol Med 1998; 28: 1301–10PubMedCrossRef Kouzis AC, Eaton WM. Absence of social networks, social support, and health services utilization. Psychol Med 1998; 28: 1301–10PubMedCrossRef
14.
go back to reference Stessman J, Ginsberg G, Maaravi Y, et al. Profile of Jerusalem’s 70 year olds: medical data. Isr J Med Sci 1996; 32: 665–87PubMed Stessman J, Ginsberg G, Maaravi Y, et al. Profile of Jerusalem’s 70 year olds: medical data. Isr J Med Sci 1996; 32: 665–87PubMed
15.
go back to reference Stessman J, Cohen A, Ginsberg GM, et al. The Jerusalem seventy-year-old longitudinal study: I. Description of the initial cross-sectional survey. Eur J Epidemiol 1995; 11: 675–84PubMedCrossRef Stessman J, Cohen A, Ginsberg GM, et al. The Jerusalem seventy-year-old longitudinal study: I. Description of the initial cross-sectional survey. Eur J Epidemiol 1995; 11: 675–84PubMedCrossRef
16.
go back to reference Yang JC, Tomlinson G, Naglie G. Medication lists for elderly patients: clinic-derived versus in-home inspection and interview. J Gen Intern Med 2001; 16: 112–5PubMedCrossRef Yang JC, Tomlinson G, Naglie G. Medication lists for elderly patients: clinic-derived versus in-home inspection and interview. J Gen Intern Med 2001; 16: 112–5PubMedCrossRef
17.
go back to reference Cohen A, Stessman J, Ginsberg GM, et al. The Jerusalem seventy year olds longitudinal study: II. Background results from the initial home interview. Eur J Epidemiol 1995; 11: 685–92PubMedCrossRef Cohen A, Stessman J, Ginsberg GM, et al. The Jerusalem seventy year olds longitudinal study: II. Background results from the initial home interview. Eur J Epidemiol 1995; 11: 685–92PubMedCrossRef
18.
go back to reference Cohen A, Ginsberg G, Friedman R, et al. Profile of Jerusalem’s 70 year olds: social data. Isr J Med Sci 1996; 32: 688–701PubMed Cohen A, Ginsberg G, Friedman R, et al. Profile of Jerusalem’s 70 year olds: social data. Isr J Med Sci 1996; 32: 688–701PubMed
20.
go back to reference Fillenbaum GG, Horner RD, Hanlon JT, et al. Factors predicting change in prescription and nonprescription drug use in a community-residing black and white elderly population. J Clin Epidemiol 1996; 49: 587–93PubMedCrossRef Fillenbaum GG, Horner RD, Hanlon JT, et al. Factors predicting change in prescription and nonprescription drug use in a community-residing black and white elderly population. J Clin Epidemiol 1996; 49: 587–93PubMedCrossRef
21.
go back to reference Sax P. Expenditure and consumption of medicines in Israel 1975–85: analysis of trends and elements of growth. Isr J Med Sci 1988; 24: 307–16PubMed Sax P. Expenditure and consumption of medicines in Israel 1975–85: analysis of trends and elements of growth. Isr J Med Sci 1988; 24: 307–16PubMed
22.
go back to reference Sax P. Recent trends in drug utilization in Israel. Isr J Med Sci 1992; 28: 718–25PubMed Sax P. Recent trends in drug utilization in Israel. Isr J Med Sci 1992; 28: 718–25PubMed
23.
go back to reference Sax P. Spending on medicines in Israel in an international context. Isr Med Assoc J 2005; 7: 286–91PubMed Sax P. Spending on medicines in Israel in an international context. Isr Med Assoc J 2005; 7: 286–91PubMed
24.
go back to reference Fuchs Z, Novikov I, Blumstein T, et al. Patterns of drug use among the community-dwelling old-old population in Israel. Isr Med Assoc J 2003; 5: 346–51PubMed Fuchs Z, Novikov I, Blumstein T, et al. Patterns of drug use among the community-dwelling old-old population in Israel. Isr Med Assoc J 2003; 5: 346–51PubMed
25.
go back to reference Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 1991; 151: 1825–32PubMedCrossRef Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 1991; 151: 1825–32PubMedCrossRef
26.
go back to reference Shah S, Cook DG. Inequalities in the treatment and control of hypertension: age, social isolation and lifestyle are more important than economic circumstances. J Hypertens 2001; 19: 1333–40PubMedCrossRef Shah S, Cook DG. Inequalities in the treatment and control of hypertension: age, social isolation and lifestyle are more important than economic circumstances. J Hypertens 2001; 19: 1333–40PubMedCrossRef
27.
go back to reference Hawkley LC, Cacioppo JT. Loneliness and pathways to disease. Brain Behav Immun 2003; 17Suppl. 1: S98–105PubMedCrossRef Hawkley LC, Cacioppo JT. Loneliness and pathways to disease. Brain Behav Immun 2003; 17Suppl. 1: S98–105PubMedCrossRef
28.
go back to reference Berkman LF. Assessing the physical health effects of social networks and social support. Ann Rev Public Health 1984; 5: 413–32CrossRef Berkman LF. Assessing the physical health effects of social networks and social support. Ann Rev Public Health 1984; 5: 413–32CrossRef
29.
go back to reference Fillenbaum GG, Hanlon JT, Corder EH, et al. Prescription and nonprescription drug use among black and white community-residing elderly. Am J Public Health 1993; 83: 1577–82PubMedCrossRef Fillenbaum GG, Hanlon JT, Corder EH, et al. Prescription and nonprescription drug use among black and white community-residing elderly. Am J Public Health 1993; 83: 1577–82PubMedCrossRef
30.
go back to reference Al-Windi A. Determinants of medicine use in a Swedish primary health care practice population. Pharmacoepidemiol Drug Saf 2005; 14: 47–51PubMedCrossRef Al-Windi A. Determinants of medicine use in a Swedish primary health care practice population. Pharmacoepidemiol Drug Saf 2005; 14: 47–51PubMedCrossRef
31.
go back to reference Hanlon JT, Schmader KE, Ruby CM, et al. Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc 2001; 49: 200–9PubMedCrossRef Hanlon JT, Schmader KE, Ruby CM, et al. Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc 2001; 49: 200–9PubMedCrossRef
32.
go back to reference Cott CA, Gignac MA, Badley EM. Determinants of self rated health for Canadians with chronic disease and disability. J Epidemiol Community Health 1999; 53: 731–6PubMedCrossRef Cott CA, Gignac MA, Badley EM. Determinants of self rated health for Canadians with chronic disease and disability. J Epidemiol Community Health 1999; 53: 731–6PubMedCrossRef
Metadata
Title
Evolution of Medication Use in Jerusalem Elders
Results from the Jerusalem Longitudinal Study
Authors
Dr Michael A. Steinman
Yoram Maaravi
Louise C. Walter
Robert Hammerman-Rozenberg
Jochanan Stessman
Publication date
01-02-2007
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 2/2007
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.2165/00002512-200724020-00005

Other articles of this Issue 2/2007

Drugs & Aging 2/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine